Karachi: Macter International Limited, a key player in the pharmaceutical sector, experienced a significant transaction involving its shares. On June 19, 2025, Shaikh Amir Naveed, an executive of the company, executed a sale of 25,000 shares at a rate of 560.80 each. This transaction was carried out in the ready market and was disclosed as per Pakistan Stock Exchange (PSX) Regulation 5.6.4, which mandates the disclosure of interests by directors, CEOs, executives, substantial shareholders, their spouses, and minors.

The sale of shares by Mr. Naveed, as reported, resulted in a reduction of his cumulative shareholding in the company to zero. This transaction falls under the category of a Very large or significant move, given its impact on the cumulative holdings of the executive.

According to information available from the Pakistan Stock Exchange (PSX), such transactions are closely monitored to ensure transparency and compliance with regulatory standards. The PSX’s designation as the primary market for securities trading in Pakistan emphasizes its role in facilitating these disclosures and maintaining market integrity.

Macter International Limited continues to be a prominent entity within the pharmaceutical industry, with its activities and stock movements being of interest to investors and market analysts alike. The sale of shares by a high-level executive could prompt further scrutiny from stakeholders and may influence market perceptions of the company’s future performance.